Skip to content
DraconiticResearch
Search Sources API
184,584 studies31 sourcesUpdated 16 min ago
Peer-reviewedCC BY-NC-NDJPGN reports

Tirzepatide use in adolescents with metabolic dysfunction‐associated steatotic liver disease (MASLD): A case series

  1. 1Children's Hospital of Philadelphia

Related

  1. Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) : A systematic review and meta-analysis
    Mohammed Alfawaz, Dareen Bajamaan, Lama Alghamdi +7
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Efficacy of plant extracts for metabolic dysfunction-associated steatotic liver disease: a network meta-analysis
    Zhenghong Xie, Tianxing Chen
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  3. Functional and Metabolic Correlates of Age- and Sex-Normalized Handgrip Strength in Children with Metabolic Dysfunction-Associated Steatotic Liver Disease
    Mohit Kehar, Carolina Jimenez-Rivera, Leah Feret +3
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Hepatocyte senescence in metabolic dysfunction–associated steatotic liver disease (MASLD)
    Xinyue Pang, Nan Geng, Chenqi Lu +5
    Hepatology communicationsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. The CYB5R3–mARC1 Redox Axis in Metabolic Dysfunction-associated Steatotic Liver Disease: Mechanistic Basis and Therapeutic Prospects across the Steatosis–Cirrhosis–Hepatocellular Carcinoma Spectrum
    Journal of Clinical and Translational HepatologyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
BibTeX
@article{perumpail2026tirzepatide,
  title = {{Tirzepatide use in adolescents with metabolic dysfunction‐associated steatotic liver disease (MASLD): A case series}},
  author = {Brandon J. Perumpail and Andrea Tou and Jennifer Panganiban},
  journal = {JPGN reports},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13656291},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Tirzepatide use in adolescents with metabolic dysfunction‐associated steatotic liver disease (MASLD): A case series
AU  - Brandon J. Perumpail
AU  - Andrea Tou
AU  - Jennifer Panganiban
PY  - 2026
DA  - 2026/10/12
JO  - JPGN reports
UR  - https://europepmc.org/article/PMC/PMC13656291
SN  - 2691-171X
ER  -